Early Feasibility Study to Assess the Safety and Effectiveness of the OnePoint Dialysis CannulaTM as a Single-Site Vascular Access Device for Hemodialysis Procedures
NCT:NCT07599085 · NOT_YET_RECRUITING
广告
NCT编号NCT07599085
状态NOT_YET_RECRUITING
开始日期2026-08-01
SponsorEvolve Medicus, Inc. (INDUSTRY)
First posted
Last updated
简要摘要
This is an early feasibility, pre-market, prospective, interventional, single-arm, non-randomized / open-label study intended to support a future pivotal IDE study for eventual FDA clearance of the study device based on the safety and efficacy of the device in cannulating arteriovenous fistulas (AVFs) for hemodialysis procedures.
官方来源
在 ClinicalTrials.gov 上查看 →数据来自 ClinicalTrials.gov API。有关最新状态,请参阅官方记录。